Bone Metabolism of the Patient with a Malignant Melanoma during the Entry Examination and the Check-up of Whole-body Bone Scintigraphy
Malignant melanoma is a malignancy located predominantly in the skin and the incidence of melanoma increases. We compared the markers of bone metabolism – osteocalcin (OC), beta-carboxyterminal cross-linked telopeptide of type I collagen (β-CrossLaps, β-CTx) and tumour marker – human epididymis prot...
Main Authors: | Jaroslav Weissensteiner, Eva Babušíková |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2016-01-01
|
Series: | Prague Medical Report |
Subjects: | |
Online Access: | https://pmr.lf1.cuni.cz/117/2/0129/ |
Similar Items
-
Comparison of the Whole-Body Bone Scintigraphy with Levels of the Markers of Bone Metabolism in Serum of Patients with Malignant Melanoma
by: Weissensteiner J., et al.
Published: (2015-05-01) -
Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males
by: Prasun Deb, et al.
Published: (2012-01-01) -
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
by: Emanuela Palmerini, et al.
Published: (2022-06-01) -
Bone metabolism markers and their correlation with body mass index in aerobic physical activity
by: Bajić Zorislava, et al.
Published: (2018-01-01) -
Secondary Hyperparathyroidism and Bone Turnover in Elderly with Bone Loss - Original Investigation
by: Nurdan Peker, et al.
Published: (2006-12-01)